Incannex Healthcare (IXHL) Return on Capital Employed (2024 - 2026)
Incannex Healthcare (IXHL) posted Return on Capital Employed of 33.5% for Q1 2026, up 4.14% sequentially from 34.95% in Q4 2025, and up 38036.0% YoY from N/an in Q1 2025.
Incannex Healthcare (IXHL) Return on Capital Employed (2024 - 2026) Analysis & Trends
Incannex Healthcare has reported Return on Capital Employed for 3 years, with the latest figure at 33.5% in Q1 2026.
- Quarterly Return on Capital Employed rose 38036.0% year-over-year to 33.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 33.5% (up 38036.0% YoY) and the FY2025 annual result came in at 202.24%, up 81.0% from the prior year.
- Return on Capital Employed climbed to 33.5% in Q1 2026 per IXHL's latest filing, from 34.95% in the prior quarter.
- Over five years, Return on Capital Employed peaked at 33.5% in Q1 2026 and troughed at 429.17% in Q3 2024.
- A 3-year average of 216.04% and a median of 209.82% in 2025 frame the typical range for Return on Capital Employed.
- The sharpest annual moves came in 2025 and 2026: Return on Capital Employed slumped 26933 bps in 2025, then jumped 38036 bps in 2026.
- Over 3 years, Return on Capital Employed stood at 367.29% in 2024, then soared by 90 bps to 34.95% in 2025, then rose by 4 bps to 33.5% in 2026.
- According to Business Quant data, Return on Capital Employed over the past three periods registered 33.5%, 34.95%, and 50.75% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 6.60% |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 17.16% |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 6.07% |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 22.04% |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -0.29% |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 18.67% |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 5.52% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Incannex Healthcare | 44.39 Mn | 44.39 Mn | - | -33.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.50% |
| Dec 31, 2025 | -34.95% |
| Sep 30, 2025 | -50.75% |
| Jun 30, 2025 | -209.82% |
| Mar 31, 2025 | -413.86% |
| Dec 31, 2024 | -367.29% |
| Sep 30, 2024 | -429.17% |
| Jun 30, 2024 | -260.52% |
| Mar 31, 2024 | -144.53% |